Kasuistikk: Tidlig vekstavvik mistenkt ved 2 trimester screening

• Referanser

• 1 www.helsedirektoratet.no/tema/bioteknologi/fosterdiagnostikk/informasjon-om-fosterdiagnostikk-til-helsepersonell-i-svangerskapsomsorgen-i-den-kommunale-helse-og-omsorgstjenesten/innledning
• 2 Salomon LJ, Alfirevic Z, Da Silva Costa F. et al. ISUOG practice guidelines: Ultrasound assessment of fetal biometry and growth. Ultrasound Obstet Gynecol 2019; 53 (06) 715-723
• 3 Marsál K. Obstetric management of intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol 2009; 23 (06) 857-870
• 4 Odland KarlsenH, Ebbing C, Acharya G. et al Norsk gynekologisk forening, veileder fødselshjelp 2020. Intrauterin veksthemming. Tilgjengelig fra: www.legeforeningen.no/foreningsledd/fagmed/norsk-gynekologisk-forening/veiledere/veileder-i-fodselshjelp/intrauterin-veksthemming/
• 5 Cafici D, Terrones A, Ramos Mejía D. Doppler assessment of the uterine arteries, Visual Encyclopedia of Ultrasound in Obstetrics and Gynecology, July 2022. www.isuog.org
• 6 Figueras F, Gratacós E. Update on the diagnosis and classification of fetal growth restriction and proposal of stage-based management protocol. Fetal Diagn Ther 2014; 36 (02) 86-98
• 7 McGoldrick E, Stewart F, Parker R. et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2020; 12 (12) CD004454
• 8 Figueras F, Gratacós E. An integrated approach to fetal growth restriction. Best Pract Res Clin Obstet Gynaecol 2017; 38: 48-58
• 9 Crowther C, Middleton P, Voysey M. et al. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis. PLoS Med 2017; 14 (10) e1002398